Allergic & Inflammatory Diseases

Vietnam’s large patient population, proven expertise, fast-track regulatory approvals, and cost-effective research environment make it a strategic hub for clinical research. With over a decade of experience, Horus CRO ensures seamless trial execution, high-quality data, and strategic insights to drive success in allergic and inflammatory disease studies.
Autoimmune Diseases

Autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, type 1 diabetes, and psoriasis affect millions in Vietnam. With over 20 ongoing clinical trials and global collaborations, Vietnam is advancing research in genetics and immunotherapy to improve treatment outcomes.
CNS Diseases

Central nervous system (CNS) disorders present a significant health challenge in Vietnam, though clinical trials in this area are still limited. As a leading CRO, Horus leverages Vietnam’s expanding research environment to deliver expert support for efficient, high-quality CNS clinical trials.
Clinical trial regulatory for Vietnam

This document offers a comprehensive overview of Vietnam’s clinical trial regulations, including approval processes for various intervention types, import licensing, compliance with ICH-GCP standards, and key legal requirements. It details the step-by-step procedures mandated by the Ministry of Health to ensure transparency and efficiency in clinical research.
Clinical Data Management & EDC Solutions

Horus offers top-tier clinical data management services through our proprietary EDC platform, ClinicalDataS. We ensure data accuracy, compliance, and efficiency by leveraging cutting-edge technology, AI-driven insights, and seamless integration—accelerating research while upholding the highest regulatory standards.
Metabolic Disorders

Metabolic disorders, including diabetes, are increasingly prevalent in Vietnam and represent a significant public health challenge. Horus, as a Clinical Research Organization (CRO), supports the design and management of research studies aimed at finding effective solutions.